As Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. continues his vocal campaign against direct-to-consumer (DTC) pharmaceutical advertising, the push to ban drug ads on television remains a contentious battleground in U.S. health policy. Kennedy, a longtime critic of the pharmaceutical industry, has made restricting these ads a cornerstone of his agenda under the Trump administration.